🇺🇸 COS with GnRH antagonists and rFSH in United States

COS with GnRH antagonists and rFSH (COS with GnRH antagonists and rFSH) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

COS with GnRH antagonists and rFSH in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is COS with GnRH antagonists and rFSH approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for COS with GnRH antagonists and rFSH in United States?

Instituto Valenciano de Infertilidad, IVI VALENCIA is the originator. The local marketing authorisation holder may differ — check the official source linked above.